When you talk about the biotechnology and pharmaceutical industries today, you will never miss out the name Marc Beers. With more than twenty years of experience in this field being active, Marc has contributed a tonne of his talent, advice, counselling and experience to the success of this field. He has been chief executive officer, director, CEO, sales and marketing manager, a husband, a father and many more. With all the companies he has ever been part of a success today, Marc shifted his focus to his latest and project Renovia, Inc., and his major interest being the general public, women in general with debilitating health conditions of the pelvic, Marc has successfully closed the deal on one of the worst health conditions affecting more women than any statistics has ever revealed “the pelvic floor disorder”. With most of his companies’ pharmaceutical product being approved by the FDA and these products being produced and approved in many countries around the world, no wonder he is among the top names in the biotechnology industry today.
His major point for his success and for companies that he has worked for in the past has been a source of fundraising. To him, any project that lacks funds will collapse even before it is due to kick off. So for his new innovation, to tackle this challenge, he made sure to seal the most important aspect of the project by securing his dream company a $42.3 million series B financing that will help his digital therapeutic and diagnostic device become a reality.
His company has partnered up with a well- known Medtech Company in Boston to produce one of its very first products to treat pelvic floor disorder which was estimated to be millions of dollars in research and time. As a result of this major breakthrough four other major health care advisors and investment companies have decided to raise more funds that will go into four more diagnostic and therapeutic products for this disease condition and on an upgrade on the “LEVA” which was the very first product that was approved and released in the market today. Though it is still performing well, it will be upgraded to suit most of the latest research that has been done so far in the field. His research will provide a greatly needed overview of disease conditions, stages, treatment options and even an estimated budget to the patient. This breakthrough has already put a smile on the faces of millions of women around the world.
In conclusion, the biotechnology industries need an innovative researcher and new research that will come up with new and improved treatment options for patients that have lost all hope in their minds about permanent health conditions. Learn mnore: https://renoviainc.com/leadership/